IMMUNOVEDA
Dead / Abandoned — Abandoned — failure to respond (as of 23 Aug 2023)
What this means for you
This application is over — abandoned 10 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88664944
- Mark type
- Stylized text
- Filed
- 23 Oct 2019
- Published for opposition
- 11 Feb 2020
- Abandoned
- 10 Aug 2023
- Attorney of record
- Arnold Braun
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical treatment of cancer; Medical diagnosis and treatment of cancer; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer
Owner
- Genesis Drug, Discovery & Development, LLC, Hamilton, NJ, US
- Genesis Drug, Discovery & Development, LLC, Hamilton, NJ, US
Prosecution history
- 23 Aug 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 23 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 23 Aug 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 09 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 May 2023 — NON-FINAL ACTION E-MAILED
- 09 May 2023 — SU - NON-FINAL ACTION - WRITTEN
- 19 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Apr 2023 — USE AMENDMENT FILED
- 04 Apr 2023 — TEAS STATEMENT OF USE RECEIVED
- 21 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2022 — SOU EXTENSION 5 GRANTED
- 14 Sept 2022 — SOU EXTENSION 5 FILED
- 14 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 13 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2022 — SOU EXTENSION 4 GRANTED